GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gland Pharma Ltd
Gland Pharma Ltd. Receives Customs Authority Order for GST Demand
REGULATORY ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 16 Jul 2026, 04:06 PM IST  ·  BSE ID: 30efea4c-f684-49f4-b6a4-37dc7ea8a7df
View Original BSE Filing (PDF)
💡
In Simple Terms
Gland Pharma received a government order for GST dues, interest, and penalty, but plans to appeal it.
🤖 AI Summary
  • Customs Authority confirmed GST demand of INR 3,52,93,678/- for FY20-21 and FY21-22.
  • Demand includes applicable interest and a penalty of INR 3,52,93,678/-.
  • Gland Pharma received the order on July 15, 2026, dated July 10, 2026.
  • Company is in the process of filing an appeal with the appellate authority.
  • Management believes there is no material impact on the company's financials.
🔢 Key Numbers — exact figures from BSE filing, not rounded
GST Demand
INR 3,52,93,678/-
Penalty
INR 3,52,93,678/-
Order Date
July 10, 2026
Receipt Date
July 15, 2026
🏢 How This Affects the Company
💰
Financial Impact
The order imposes a demand of INR 3,52,93,678/- for GST, plus interest and an equal amount for penalty. Management states no material financial impact, pending appeal.
⚠️
Risk Impact
The order introduces a regulatory risk related to the GST demand. The company is mitigating this by filing an appeal.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders; monitor appeal process updates.
👤
Who Is Affected
All shareholders are affected by potential financial liabilities if the appeal is unsuccessful.
🔍
Management Signal
Management's decisive action to appeal signals confidence in contesting the authority's order and protecting company finances.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Company's appeal filing status with the appellate authority.
Updates on the resolution of the GST demand and penalty.
Management commentary on appeal progress in future disclosures.
MEDIUM RISK Significant financial demand including penalty and interest issued by Customs Authority.
💡 Investor Takeaway
Gland Pharma faces a confirmed GST demand of INR 3,52,93,678/- plus interest and penalty for FY20-21/FY21-22. The company is appealing and assessing no material financial impact.
⚖️ Strengths & Concerns

✅ Positives

  • Management's assessment of no material impact on financials provides clarity pending appeal resolution.
  • Company is proactively pursuing an appeal, indicating a commitment to contesting the demand.

⚠️ Concerns

  • A confirmed GST demand of INR 3,52,93,678/- along with an equal penalty and applicable interest has been issued.
  • The company is required to pay INR 3,52,93,678/- plus interest and penalty under the order.
❓ Frequently Asked Questions
What is the total GST demand issued to Gland Pharma Ltd. by the Customs Authority?
The Customs Authority issued a GST demand of INR 3,52,93,678/- for the period FY2020-21 and FY2021-22.
What is the penalty amount imposed on Gland Pharma Ltd.?
Gland Pharma Ltd. has been subjected to a penalty of INR 3,52,93,678/- under the Customs Act, 1962.
When did Gland Pharma Ltd. receive the order from the Customs Authority?
Gland Pharma Ltd. received the order on July 15, 2026, which was dated July 10, 2026.
What action is Gland Pharma Ltd. taking regarding the GST demand?
The company is in the process of filing a necessary appeal with the appellate authority against the order.
What is the management's assessment of the impact of this order on Gland Pharma's financials?
Management is of the view that there is no material impact on the company's financials due to the said order.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.